CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat

1y ago

CINC

PremiumThe Fly

AstraZeneca commences tender offer to acquire CinCor Pharma for $26.00 per share

1y ago

AZN

CINC

PremiumThe Fly

Largest borrow rate increases among liquid names

1y ago

HUT

SWN

PremiumThe Fly

CinCor Pharma downgraded to Equal Weight from Overweight at Barclays

1y ago

AZN

CINC

More CINC News >

CINC News on the Web

2023-01-26

CinCor CEO: acquisition by AstraZeneca was more than a year in the making

American City Business Journals

Neutral

2023-01-23

AstraZeneca Commencs Tender Offer To Buy CinCor Pharma

rttnews

Neutral

2023-01-18

CinCor Pharma Inc (CINC) has gained 0.42% in a Week, Should You Buy?

Investors Observer

Neutral

2023-01-16

6 big deal reports: Microsoft eyes $10B OpenAI investment

Investing.com

Neutral

2023-01-16

6 big deal reports: Microsoft eyes $10B OpenAI investment

Investing.com

Neutral

2023-01-13

Why These Two Biotech Stocks Blasted Higher This Week

The Motley Fool

Neutral

2023-01-11

Biotech Stock Roundup: REGN Down on Eylea Data, CINC Surges on AZN Offer & More

Yahoo Finance

Neutral

2023-01-10

Should You Buy CinCor Pharma Inc (CINC) Stock After it Has Gained 145.53% in a Week?

Investors Observer

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CINC’s Media Buzz Sentiment?

Currently, no data Available

What is CINC’s weekly average amount of articles?

Currently, no data Available

What is CINC’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

HOOKHookipa Pharma

PRVBProvention Bio

BLCMBellicum Pharmaceuticals

VSTMVerastem

ARDSAridis Pharmaceuticals

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing